ARTICLE | Company News
Non-approvable letter for Pharmacia's Vestra
May 18, 2001 7:00 AM UTC
PHA received a non-approvable letter from the FDA for its Vestra reboxetine selective norepinephrine reuptake inhibitor to treat depression. The original Vestra NDA was submitted in 1998, and containe...